ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

Clinical trial NCT03911505 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03911505
Sponsor: Amicus Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pompe Disease (Late-onset)

Start date: 2020-02-13
Primary completion: 2026-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.